Italian Researchers Cut Prosthetic Limb Weight by 25% Using Digital Design
Published on 07/24/2026 at 07:54 | Redaktion boerse-global.de
A team of Italian scientists has developed a digital workflow that reduces the weight of prosthetic sockets by roughly 25 percent, producing a prototype from Polyamid 12 that weighed just 373 grams while maintaining high structural strength.
The breakthrough comes amid a broader push across manufacturing and workplace design to reduce physical strain on workers and users alike. Similar lattice-structure approaches are now being applied to seating and positioning systems: new wheelchair cushions use 3D-printed grids with variable density to improve pressure relief and breathability. In pediatric care, a modular seating system has been introduced that can grow with a child over several years, eliminating the need for frequent refittings.
Automation Eases Repetitive Strain on Factory Floors
Packaging machinery specialist Syntegon has developed automated tray-loading systems for vials and cartridges that reach throughputs of up to 24,000 vials per hour (model GLT) and 36,000 cartridges per hour (model TLU-C). The company says the goal is not just speed but gentle product handling and full traceability.
A key side benefit: automation reduces the physical toll of repetitive motion tasks. Digital assistance tools are also entering the picture. Blue Mountain has introduced RAM Discover, an AI-powered intelligence engine for asset management in the life-sciences sector, enabling root-cause analysis and benchmarking through natural-language queries.
Reducing physical strain on workers is a growing priority across industries, and proper risk assessment is the foundation of any effective workplace safety programme. A free toolkit provides 41 ready-to-use templates and checklists to help you document hazards and stay compliant with UK regulations. Download the free Risk Assessment Toolkit
Gerresheimer Doubles Asian Capacity with New Chinese Plant
Pharmaceutical packaging supplier Gerresheimer has opened a new facility in Zhenjiang Dagang, China, spanning 40,000 square meters and including a 2,700-square-meter ISO 8 cleanroom. The plant doubles the company’s production capacity in the region and currently employs 250 workers.
The building, certified to LEED Gold standards, also houses an ISO 7 laboratory. Gerresheimer said the expansion responds to rising demand for primary pharmaceutical packaging across Asia.
Hamburg Site Prepares for Advanced Cell and Gene Therapies
In Germany, PROVIREX has established a 230-square-meter S3 GMP cleanroom production area for Advanced Therapy Medicinal Products (ATMPs), including CAR-T cells, at its tecHHub site in Hamburg. The facility covers cleanroom classes A through D and can accommodate up to seven automated platforms.
GMP certification is still underway. Once completed, the company will be able to fully use the capacity for manufacturing cell and gene therapies.
Ergonomics Beyond the Cleanroom
Outside pharmaceutical settings, manufacturers of large-scale components such as hydrogen transport containers have developed specialized double-sided assembly platforms that combine collective fall protection with short setup times, blending safety and efficiency.
Office furniture is also getting an ergonomic upgrade. Innovations like Niels Diffrient’s “Different Lounge” feature motorized backrest and headrest adjustments along with integrated charging points to reduce physical fatigue at screen-based workstations. These “activity-based working” concepts are being implemented at Schwarz Digits’ new location in Bad Friedrichshall, which offers workspace for up to 5,500 employees and more than 500 creative rooms.
Novartis to Sell Life Science Campus in Kundl
INNEXIS Holding plans to acquire the Life Science Campus in Kundl, Austria, from Novartis at the turn of 2027. The site covers more than 260,000 square meters and includes over 100 buildings. Novartis will continue its core research and production activities in existing facilities on the campus.
The acquiring company aims to attract additional life-science firms to the site, leveraging shared infrastructure and pursuing sustainable site development through a new operator company.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
